Clinical Trial Detail

NCT ID NCT01729845
Title Decitabine Followed By Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

acute myeloid leukemia

Therapies

Cytarabine + Etoposide + Mitoxantrone

Decitabine

Age Groups: adult

No variant requirements are available.